Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
1 hedge funds and large institutions have $10K invested in Adial Pharmaceuticals Warrant in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
41% less capital invested
Capital invested by funds: $17K → $10K (-$7K)
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $10K | – | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| – | -$3K | -4,300 | Closed |
|
ADILW Hedge Fund Activity: Q4 2021 in Review
1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q4 2021, worth a combined $10K — down 41% from $17K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ADILW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Wolverine Asset Management, exiting entirely with an estimated $3K sold.
- 1 institutional investor held Adial Pharmaceuticals Warrant (ADILW) as of Q4 2021, down from 3 in Q3 2021.
- Funds reported $10K of Adial Pharmaceuticals Warrant stock for Q4 2021, down 41% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals Warrant positions in Q4 2021 and 2 closed out, a net change of -2 holders.
- The largest Adial Pharmaceuticals Warrant seller in Q4 2021 was Wolverine Asset Management, an estimated $3K sold.
Based on aggregated 13F filings for Q4 2021.